Regulatory status: IVD, FDA Class I
60-0142-7 7mL RTU
61-0142 1mL concentrate
In a panel of antibodies, e.g. CK19, CK7, CK20, CA19-9, this antibody can be an aid for differential diagnosis of adenocarcinomas.